AAX Biotech, a biotechnology company specialising in antibody therapeutics, and Vascurie, a biopharmaceutical company ...

MindWalk Holdings Corp. ("MindWalk" or the "Company") today announced the discovery and validation of monoclonal antibodies and intrabodies that selectively target misfolded, pathogenic TDP-43, a ...

This article and associated images are based on a poster originally authored by Amy Turner, Poppy Nathan, Yanan Lu, Deepa Shankar, Danielle Callahan, Lion Lian and Jason Li and presented at ELRIG Drug ...

BACKGROUND Toxocariasis is a neglected global zoonosis. The immunological diagnosis has setbacks that hinder further knowledge about its pathology, epidemiology, and public control measures, and lack ...

Most companies want to scale efficiently, but few truly understand the mechanics of how work gets done. That’s where business process mapping comes in. Business process mapping visually outlines how ...

Finding the most suitable antibodies from the vast pool of potential products is a challenge. Able helps scientists pinpoint the right antibody based on their research needs, while also providing all ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. P2X7 receptors are important drug targets involved in pathologies ranging from ...

A vaccine developed against one strain of a virus is a remarkable achievement. But a “universal vaccine” that could protect from all forms of that pathogen is the holy grail. For decades, researchers ...

Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Padualaan 8, Utrecht 3584CH, the ...

A team at Scripps Research has created a microchip that can rapidly reveal how a person's antibodies respond to viruses using only a drop of blood. This game-changing technology, called mEM, condenses ...

The new system, known as microfluidic EM-based polyclonal epitope mapping (mEM), offers researchers faster, clearer insights that could help accelerate vaccine development and antibody discovery. LA ...